Med mindre fortsat behandling med losartan/ hydrochlorthiazid anses for essentiel, bør patienter, der planlægger graviditet, skiftes til alternativ antihypertensiv behandling, som har en etableret sikkerhedsprofil for anvendelse under graviditet.
Unless continued Losartan/ HTCZ therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy.